M K Proteins Share Price
Sector: Food Processing
7.48 -0.17 (-2.22%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
7.27
Today’s High
7.75
52 Week Low
5.37
52 Week High
12.99
7.50 -0.12 (-1.57%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
7.32
Today’s High
7.79
52 Week Low
5.40
52 Week High
12.88
Key Metrics
- Market Cap (In Cr) 280.78
- Beta 0.55
- Div. Yield (%) 0
- P/B 4.05
- TTM P/E 27.36
- Sector P/E 20.84
- D/E 0.01
- Open Price 7.5
- Prev Close 7.65
M K Proteins Analysis
Price Analysis
-
1 Week-2.72%
-
3 Months24.58%
-
6 Month-8.65%
-
YTD-7.86%
-
1 Year-38.57%
Risk Meter
- 59% Low risk
- 59% Moderate risk
- 59% Balanced Risk
- 59% High risk
- 59% Extreme risk
M K Proteins Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 267.71
- Selling/ General/ Admin Expenses Total
- 2.75
- Depreciation/ Amortization
- 0.35
- Other Operating Expenses Total
- 12.83
- Total Operating Expense
- 255.63
- Operating Income
- 12.08
- Net Income Before Taxes
- 11.45
- Net Income
- 8.4
- Diluted Normalized EPS
- 0.22
- Period
- 2025
- Total Assets
- 130.57
- Total Liabilities
- 61.1
- Total Equity
- 69.47
- Tangible Book Valueper Share Common Eq
- 1.85
- Period
- 2025
- Cashfrom Operating Activities
- -16.13
- Cashfrom Investing Activities
- -1.48
- Cashfrom Financing Activities
- 17.55
- Net Changein Cash
- -0.06
- Period
- 2024
- Total Revenue
- 245.57
- Selling/ General/ Admin Expenses Total
- 2.79
- Depreciation/ Amortization
- 0.53
- Other Operating Expenses Total
- 9.74
- Total Operating Expense
- 229.48
- Operating Income
- 16.09
- Net Income Before Taxes
- 15.47
- Net Income
- 11.21
- Diluted Normalized EPS
- 0.3
- Period
- 2024
- Total Assets
- 96.25
- Total Liabilities
- 35.17
- Total Equity
- 61.08
- Tangible Book Valueper Share Common Eq
- 1.63
- Period
- 2024
- Cashfrom Operating Activities
- 32.42
- Cashfrom Investing Activities
- -5.88
- Cashfrom Financing Activities
- -26.51
- Net Changein Cash
- 0.03
- Period
- 2023
- Total Revenue
- 314.86
- Selling/ General/ Admin Expenses Total
- 1.76
- Depreciation/ Amortization
- 0.76
- Other Operating Expenses Total
- 10.87
- Total Operating Expense
- 298.58
- Operating Income
- 16.28
- Net Income Before Taxes
- 14.6
- Net Income
- 10.65
- Diluted Normalized EPS
- 0.28
- Period
- 2023
- Total Assets
- 104.93
- Total Liabilities
- 54.66
- Total Equity
- 50.27
- Tangible Book Valueper Share Common Eq
- 1.34
- Period
- 2023
- Cashfrom Operating Activities
- -7.7
- Cashfrom Investing Activities
- 0.01
- Cashfrom Financing Activities
- 7.74
- Net Changein Cash
- 0.06
- Period
- 2022
- Total Revenue
- 255.89
- Selling/ General/ Admin Expenses Total
- 1.82
- Depreciation/ Amortization
- 0.91
- Other Operating Expenses Total
- 11.3
- Total Operating Expense
- 241.15
- Operating Income
- 14.74
- Net Income Before Taxes
- 14.04
- Net Income
- 10.18
- Diluted Normalized EPS
- 0.27
- Period
- 2022
- Total Assets
- 86.15
- Total Liabilities
- 46.54
- Total Equity
- 39.6
- Tangible Book Valueper Share Common Eq
- 1.06
- Period
- 2022
- Cashfrom Operating Activities
- -10.12
- Cashfrom Investing Activities
- -1.53
- Cashfrom Financing Activities
- 11.66
- Net Changein Cash
- 0.01
- Period
- 2021
- Total Revenue
- 311.1
- Selling/ General/ Admin Expenses Total
- 1.55
- Depreciation/ Amortization
- 0.91
- Other Operating Expenses Total
- 7.82
- Total Operating Expense
- 296.07
- Operating Income
- 15.02
- Net Income Before Taxes
- 14.32
- Net Income
- 10.39
- Diluted Normalized EPS
- 0.28
- Period
- 2021
- Total Assets
- 67.35
- Total Liabilities
- 38.01
- Total Equity
- 29.34
- Tangible Book Valueper Share Common Eq
- 0.78
- Period
- 2021
- Cashfrom Operating Activities
- 5.54
- Cashfrom Investing Activities
- -0.21
- Cashfrom Financing Activities
- -5.44
- Net Changein Cash
- -0.11
- Period
- 2017
- Total Revenue
- 164.53
- Selling/ General/ Admin Expenses Total
- 1.77
- Depreciation/ Amortization
- 1.21
- Other Operating Expenses Total
- 11.58
- Total Operating Expense
- 160.87
- Operating Income
- 3.66
- Net Income Before Taxes
- 1.51
- Net Income
- 0.99
- Diluted Normalized EPS
- 0.04
- Period
- 2017
- Total Assets
- 46.57
- Total Liabilities
- 42.31
- Total Equity
- 4.26
- Tangible Book Valueper Share Common Eq
- 0.17
- Period
- 2017
- Cashfrom Operating Activities
- -3.58
- Cashfrom Investing Activities
- -1.36
- Cashfrom Financing Activities
- 4.58
- Net Changein Cash
- -0.36
- Period
- 2016
- Total Revenue
- 144.75
- Selling/ General/ Admin Expenses Total
- 1.3
- Depreciation/ Amortization
- 0.9
- Other Operating Expenses Total
- 9.42
- Total Operating Expense
- 141.38
- Operating Income
- 3.37
- Net Income Before Taxes
- 1.05
- Net Income
- 0.72
- Diluted Normalized EPS
- 0.02
- Period
- 2016
- Total Assets
- 39.08
- Total Liabilities
- 35.81
- Total Equity
- 3.27
- Tangible Book Valueper Share Common Eq
- 0.09
- Period
- 2016
- Cashfrom Operating Activities
- -4.23
- Cashfrom Investing Activities
- -1.88
- Cashfrom Financing Activities
- 6.49
- Net Changein Cash
- 0.38
- Period
- 2025-03-31
- Total Revenue
- 137.2
- Selling/ General/ Admin Expenses Total
- 0.82
- Depreciation/ Amortization
- 0.09
- Other Operating Expenses Total
- 7.76
- Total Operating Expense
- 132.63
- Operating Income
- 4.57
- Net Income Before Taxes
- 3.92
- Net Income
- 2.8
- Diluted Normalized EPS
- 0.07
- Period
- 2025-03-31
- Total Assets
- 130.57
- Total Liabilities
- 61.1
- Total Equity
- 69.47
- Tangible Book Valueper Share Common Eq
- 1.85
- Period
- 2025-03-31
- Cashfrom Operating Activities
- -16.13
- Cashfrom Investing Activities
- -1.48
- Cashfrom Financing Activities
- 17.55
- Net Changein Cash
- -0.06
- Period
- 2024-12-31
- Total Revenue
- 39.48
- Selling/ General/ Admin Expenses Total
- 0.64
- Depreciation/ Amortization
- 0.11
- Other Operating Expenses Total
- 2.05
- Total Operating Expense
- 37.8
- Operating Income
- 1.68
- Net Income Before Taxes
- 1.86
- Net Income
- 1.38
- Diluted Normalized EPS
- 0.04
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 33.69
- Selling/ General/ Admin Expenses Total
- 0.62
- Depreciation/ Amortization
- 0.07
- Other Operating Expenses Total
- 1.32
- Total Operating Expense
- 31.53
- Operating Income
- 2.16
- Net Income Before Taxes
- 2.34
- Net Income
- 1.74
- Diluted Normalized EPS
- 0.04
- Period
- 2024-09-30
- Total Assets
- 71.06
- Total Liabilities
- 5.76
- Total Equity
- 65.3
- Tangible Book Valueper Share Common Eq
- 1.74
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 38.39
- Cashfrom Investing Activities
- -19.26
- Cashfrom Financing Activities
- -19.11
- Net Changein Cash
- 0.02
- Period
- 2024-06-30
- Total Revenue
- 57.33
- Selling/ General/ Admin Expenses Total
- 0.66
- Depreciation/ Amortization
- 0.07
- Other Operating Expenses Total
- 1.69
- Total Operating Expense
- 53.67
- Operating Income
- 3.67
- Net Income Before Taxes
- 3.34
- Net Income
- 2.48
- Diluted Normalized EPS
- 0.07
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2017-03-31
- Total Revenue
- 53.6
- Selling/ General/ Admin Expenses Total
- 0.45
- Depreciation/ Amortization
- 0.3
- Other Operating Expenses Total
- 2.92
- Total Operating Expense
- 52
- Operating Income
- 1.59
- Net Income Before Taxes
- 0.91
- Net Income
- 0.57
- Diluted Normalized EPS
- 0.02
- Period
- 2017-03-31
- Total Assets
- 46.57
- Total Liabilities
- 42.31
- Total Equity
- 4.26
- Tangible Book Valueper Share Common Eq
- 0.17
- Period
- 2017-03-31
- Cashfrom Operating Activities
- -3.58
- Cashfrom Investing Activities
- -1.36
- Cashfrom Financing Activities
- 4.58
- Net Changein Cash
- -0.36
- Period
- 2016-12-31
- Total Revenue
- 110.94
- Selling/ General/ Admin Expenses Total
- 1.32
- Depreciation/ Amortization
- 0.91
- Other Operating Expenses Total
- 8.66
- Total Operating Expense
- 108.87
- Operating Income
- 2.07
- Net Income Before Taxes
- 0.6
- Net Income
- 0.41
- Diluted Normalized EPS
- 0.01
- Period
- 2016-12-31
- Total Assets
- 42.46
- Total Liabilities
- 38.78
- Total Equity
- 3.68
- Tangible Book Valueper Share Common Eq
- 0.1
- Period
- 2016-12-31
- Cashfrom Operating Activities
- 8.55
- Cashfrom Investing Activities
- -0.94
- Cashfrom Financing Activities
- -7.98
- Net Changein Cash
- -0.37
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
M K Proteins Technical
Moving Average
SMA
- 5 Day7.61
- 10 Day7.86
- 20 Day7.46
- 50 Day7.09
- 100 Day6.98
- 300 Day7.87
M K Proteins Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Vijay Solvex
- 897.8
- 20.8
- 2.37
- 1387
- 728
- 287.15
- Ponni Sugars Erode
- 332
- -1.1
- -0.33
- 598.15
- 261.2
- 285.55
- M K Proteins
- 7.48
- -0.17
- -2.22
- 12.99
- 5.37
- 280.78
- K M Sugars Mills
- 28.8
- -0.01
- -0.03
- 46.25
- 22.5
- 264.13
- Coastal Corporation
- 38.61
- 0.35
- 0.91
- 64.49
- 33.7
- 257.77
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Vijay Solvex
- 15.59
- 0.84
- 11.14
- 1.5
- Ponni Sugars Erode
- 14.82
- 0.54
- 7.63
- 9.05
- M K Proteins
- 34.09
- 4.05
- -
- -
- K M Sugars Mills
- 7.48
- 0.78
- 11.82
- 5.25
- Coastal Corporation
- 57.15
- 0.98
- 4.38
- 2
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 23-May-25
- Audited Results
- 13-Feb-25
- Quarterly Results & Others
- 14-Nov-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results
- 29-May-24
- Audited Results
- 30-Jan-24
- Quarterly Results & Bonus issue
- 14-Nov-23
- Quarterly Results
- 10-Nov-23
- Quarterly Results
- 23-Sept-23
- Stock Split
- 14-Aug-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 30-Sept-24
- 16-Sept-24
- AGM
- 05-Mar-24
- 02-Feb-24
- POM
- 26-Oct-23
- 25-Sept-23
- POM
- 29-Sept-23
- 15-Sept-23
- AGM

- Announced on
- Record Date
- Ex-Bonus
- Description
- 30-Jan-24
- 15-Mar-24
- 15-Mar-24
- Bonus issue in the ratio of 2:1 of Re. 1/-.
- 14-Nov-22
- 03-Feb-23
- 03-Feb-23
- Bonus issue in the ratio of 2:1 of Rs. 10/-.
- Ex-Splits
- Old FV
- New FV
- Description
- 10-Nov-23
- 10
- 1
- Stock split from Rs. 10/- to Re. 1/-.
